Quercetin and prostate disease

Seminars in Preventive and Alternative Medicine

Volumn 3, Issue 2, 2007, Pages 62-66

  Shoskes, Daniel A ^a   Nickel, J Curtis ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BEE POLLEN EXTRACT PLUS BROMELAIN PLUS PAPAIN PLUS QUERCETIN; BEE POLLEN EXTRACT PLUS QUERCETIN PLUS SITOSTEROL; BP Q; BROMELAIN; BROMELAIN PLUS PAPAIN PLUS QUERCETIN; CERNITIN; DIAZEPAM; NORTRIPTYLINE; PAPAIN; PLACEBO; POLLEN EXTRACT; PROSTA Q; PYGEUM AFRICANUM EXTRACT; Q UROL; QUERCETIN; QUINOLONE; SABAL EXTRACT; SITOSTEROL; STEROID 5ALPHA REDUCTASE; UNCLASSIFIED DRUG; ZINC;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTHRALGIA; BLADDER DISEASE; CANCER INHIBITION; CHRONIC PROSTATITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIETARY INTAKE; DRUG ABSORPTION; DRUG EFFICACY; DRUG RESPONSE; DRUG STRUCTURE; HUMAN; NAUSEA; PELVIC FLOOR MUSCLE TRAINING; PELVIS PAIN SYNDROME; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; RECOMMENDED DRUG DOSE; REVIEW;

EID: 39549107757     PISSN: 15564061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spre.2007.08.003     Document Type: Review

References (41)

1. Hollman PC, Katan MB: Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 20:237-248, 1998
2. Azuma K, Ippoushi K, Ito H, et al: Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. Biosci Biotechnol Biochem 67:2548-2555, 2003
3. Hollman PC, van Trijp JM, Buysman MN, et al: Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man FEBS Lett 418:152-156, 1997
4. Murota K, Terao J: Antioxidative flavonoid quercetin: Implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417:12-17, 2003
5. Aherne SA, O'Brien NM: Mechanism of protection by the flavonoids, quercetin and rutin, against tert-butylhydroperoxide and menadione-induced DNA single strand breaks in Caco-2 cells. Free Radical Biol Med 29:507-514, 2000
6. Chen ZY, Chan PT, Ho KY, et al: Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. Chem Phys Lipids 79:157-163, 1996
7. Guardia T, Rotelli AE, Juarez AO, et al: Anti-inflammatory properties of plant flavonoids: Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56:683-687, 2001
8. Liu J, Li X, Yue Y, et al: The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol Immunol 2:455-460, 2005
9. Sato M, Miyazaki T, Kambe F, et al: Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 24:1680-1684, 1997
10. Nair MP, Mahajan S, Reynolds JL, et al: The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 13:319-328, 2006
11. Garcia-Medjavilla V, Crespo I, Collado PS, et al: The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol 557:221-229, 2007
12. Alexander RB, Ponniah S, Hasday J, et al: Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 52:744, 1998
13. de Vries JH, Janssen PL, Hollman PC, et al: Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett 114:1997
14. Hung H: Dietary quercetin inhibits proliferation of lung carcinoma cells. Forum Nutr 60:146-157, 2007
15. Nothlings U, Murphy SP, Wilkens LR, et al: Flavonols and pancreatic cancer risk: The multiethnic cohort study. Am J Epidemiol 166:924-931, 2007
16. Theodoratou E, Kyle J, Cetnarskyj R, et al: Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16:684-693, 2007
17. Knekt P, Kumpulainen J, Jarvinen R, et al: Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568, 2002
18. McNaughton Collins M, Fowler FJ Jr, Elliott DB, et al: Diagnosing and treating chronic prostatitis: Do urologists use the four-glass test? Urology 55:403-407, 2000
19. Shoskes DA, Shahed AR: Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome. Tech Urol 6:240-242, 2000
20. John H, Barghorn A, Funke G, et al: Noninflammatory chronic pelvic pain syndrome: Immunological study in blood, ejaculate and prostate tissue. Eur Urol 39:72-78, 2001
21. Shahed AR, Shoskes DA: Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: Correlation with gram positive bacterial growth and treatment response. J Androl 21:669-675, 2000
22. Basyigit I, Yildiz F, Ozkara SK, et al: The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data. Ann Pharmacother 38:1400-1405, 2004
23. Anderson D, Dobrzynska MM, Basaran N, et al: Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat Res 402:269-277, 1998
24. Phillips SA, Olson EB, Lombard JH, et al: Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J Appl Physiol 100:1117-1123, 2006
25. Shoskes DA: Use of the bioflavonoid quercetin in patients with long-standing chronic prostatitis. J Am Neutraceutical Assoc 2:18-21, 1999
26. Shoskes DA, Zeitlin SI, Shahed A, et al: Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 54:960-963, 1999
27. Rajasekaran M, Hellstrom WJ, Naz RK, et al: Oxidative stress and interleukins in seminal plasma during leukocytospermia. Fertil Steril 64:166-173, 1995
28. Shahed AR, Shoskes DA: Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 166:1738-1741, 2001
29. Aziz NH, Farag SE, Mousa LA, et al: Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios 93:43-54, 1998
30. Plaper A, Golob M, Hafner I, et al: Characterization of quercetin binding site on DNA gyrase. Biochem Biophys Res Commun 306:530, 2003
31. Lepor H: Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 6:S3-S10, 2004 (suppl 9)
32. Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol 175:217-220; discussion 220-221, 2006
33. Wilt TJ, Ishani A, Rutks I, et al: Phytotherapy for benign prostatic hyperplasia. Public Health Nutr 3:459-472, 2000
34. Kramer G, Mitteregger D, Marberger M: Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51:1202-1216, 2007
35. Konig JE, Senge T, Allhoff EP, et al: Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 58:121-129, 2004
36. Ruiz PA, Braune A, Holzlwimmer G, et al: Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137: 1208-1215, 2007
37. Penson DF, Chan JM: Prostate cancer. J Urol 177:2020-2029, 2007
38. McCann SE, Ambrosone CB, Moysich KB, et al: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53:33-41, 2005
39. Knowles LM, Zigrossi DA, Tauber RA, et al: Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 38:116-122, 2000
40. Yuan H, Pan Y, Young CY: Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett 213:155-163, 2004
41. Kim YH, Lee YJ: TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J Cell Biochem 100:998-1009, 2007